Inflammatory bowel diseases are represented by two idiopathic disorders, which include ulcerative colitis and Crohn's disease. Ulcerative colitis is restricted to the colon and involves uncertain and inflammation of the lining (mucosa) of the large intestine. Crohn's disease, on the other hand, can involve the mucosa of the small and/or large intestine and may involve deeper layers of the bowel wall. The present invention is a combination of 5-aminosalicylic acid and one or more antioxidants (e.g., N-acetylcysteine) for treating such inflammatory bowel diseases.

 
Web www.patentalert.com

< Six degree of freedom alignment display for medical procedures

> Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

> Melanocortin receptor templates, peptides and use thereof

~ 00570